1. Home
  2. LGVN vs ENSV Comparison

LGVN vs ENSV Comparison

Compare LGVN & ENSV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LGVN
  • ENSV
  • Stock Information
  • Founded
  • LGVN 2014
  • ENSV N/A
  • Country
  • LGVN United States
  • ENSV United States
  • Employees
  • LGVN N/A
  • ENSV N/A
  • Industry
  • LGVN Medicinal Chemicals and Botanical Products
  • ENSV Oilfield Services/Equipment
  • Sector
  • LGVN Health Care
  • ENSV Energy
  • Exchange
  • LGVN Nasdaq
  • ENSV Nasdaq
  • Market Cap
  • LGVN 7.8M
  • ENSV 7.2M
  • IPO Year
  • LGVN 2021
  • ENSV N/A
  • Fundamental
  • Price
  • LGVN $4.39
  • ENSV $0.25
  • Analyst Decision
  • LGVN Strong Buy
  • ENSV
  • Analyst Count
  • LGVN 1
  • ENSV 0
  • Target Price
  • LGVN $12.00
  • ENSV N/A
  • AVG Volume (30 Days)
  • LGVN 24.4M
  • ENSV 963.8K
  • Earning Date
  • LGVN 08-09-2024
  • ENSV 08-12-2024
  • Dividend Yield
  • LGVN N/A
  • ENSV N/A
  • EPS Growth
  • LGVN N/A
  • ENSV N/A
  • EPS
  • LGVN N/A
  • ENSV N/A
  • Revenue
  • LGVN $978,000.00
  • ENSV $22,938,000.00
  • Revenue This Year
  • LGVN $137.24
  • ENSV $36.41
  • Revenue Next Year
  • LGVN $50.77
  • ENSV $18.74
  • P/E Ratio
  • LGVN N/A
  • ENSV N/A
  • Revenue Growth
  • LGVN N/A
  • ENSV 4.39
  • 52 Week Low
  • LGVN $0.77
  • ENSV $0.15
  • 52 Week High
  • LGVN $37.50
  • ENSV $0.50
  • Technical
  • Relative Strength Index (RSI)
  • LGVN 71.83
  • ENSV 58.64
  • Support Level
  • LGVN $3.80
  • ENSV $0.22
  • Resistance Level
  • LGVN $6.40
  • ENSV $0.24
  • Average True Range (ATR)
  • LGVN 0.53
  • ENSV 0.02
  • MACD
  • LGVN 0.28
  • ENSV 0.00
  • Stochastic Oscillator
  • LGVN 59.31
  • ENSV 72.46

About LGVN Longeveron Inc.

Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.

About ENSV Enservco Corporation

Enservco Corp operates in the oil and gas industry. It offers well enhancement and fluid management services to the domestic onshore oil and natural gas industry. The services include frac water heating, hot oiling, pressure testing, acidizing, bacteria and scale treatment, freshwater and saltwater hauling, fluid disposal, frac tank rental, well site construction, and other general oil field services. The company's reportable business segments are Production Services and Completion and Other Services, which derives maximum revenue. It operates in geographically diverse regions of the United States.

Share on Social Networks: